175 related articles for article (PubMed ID: 24396142)
21. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A
Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701
[TBL] [Abstract][Full Text] [Related]
22. Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier.
Robillard KR; Hoque T; Bendayan R
J Pharmacol Exp Ther; 2012 Jan; 340(1):96-108. PubMed ID: 21990609
[TBL] [Abstract][Full Text] [Related]
23. HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2).
Gupta A; Zhang Y; Unadkat JD; Mao Q
J Pharmacol Exp Ther; 2004 Jul; 310(1):334-41. PubMed ID: 15007102
[TBL] [Abstract][Full Text] [Related]
24. Application and limitation of inhibitors in drug-transporter interactions studies.
Wang Q; Strab R; Kardos P; Ferguson C; Li J; Owen A; Hidalgo IJ
Int J Pharm; 2008 May; 356(1-2):12-8. PubMed ID: 18272304
[TBL] [Abstract][Full Text] [Related]
25. Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes.
Di Marco A; Yao D; Laufer R
Eur J Biochem; 2003 Sep; 270(18):3768-77. PubMed ID: 12950260
[TBL] [Abstract][Full Text] [Related]
26. ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?
Steinbach D; Legrand O
Leukemia; 2007 Jun; 21(6):1172-6. PubMed ID: 17429427
[TBL] [Abstract][Full Text] [Related]
27. Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513.
Salphati L; Plise EG; Li G
Eur J Pharm Sci; 2009 Jun; 37(3-4):463-8. PubMed ID: 19491037
[TBL] [Abstract][Full Text] [Related]
28. Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
Kühnle M; Egger M; Müller C; Mahringer A; Bernhardt G; Fricker G; König B; Buschauer A
J Med Chem; 2009 Feb; 52(4):1190-7. PubMed ID: 19170519
[TBL] [Abstract][Full Text] [Related]
29. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure.
Gedeon C; Behravan J; Koren G; Piquette-Miller M
Placenta; 2006; 27(11-12):1096-102. PubMed ID: 16460798
[TBL] [Abstract][Full Text] [Related]
30. Interactions of cyclosporin a with breast cancer resistance protein.
Xia CQ; Liu N; Miwa GT; Gan LS
Drug Metab Dispos; 2007 Apr; 35(4):576-82. PubMed ID: 17220244
[TBL] [Abstract][Full Text] [Related]
31. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
[TBL] [Abstract][Full Text] [Related]
32. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
34. Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla.
Nguyen VT; Darbour N; Bayet C; Doreau A; Raad I; Phung BH; Dumontet C; Di Pietro A; Dijoux-Franca MG; Guilet D
Fitoterapia; 2009 Jan; 80(1):39-42. PubMed ID: 18940238
[TBL] [Abstract][Full Text] [Related]
35. Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A.
Ejendal KF; Hrycyna CA
Mol Pharmacol; 2005 Mar; 67(3):902-11. PubMed ID: 15598974
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta.
Gedeon C; Anger G; Piquette-Miller M; Koren G
Placenta; 2008 Jan; 29(1):39-43. PubMed ID: 17923155
[TBL] [Abstract][Full Text] [Related]
37. Ketoconazole-associated preferential increase in dopamine D2 receptor occupancy in striatum compared to pituitary in vivo: role for drug transporters?
Reist C; Wu JC; Lilja Y; Mukherjee J; Gripeos D; Constantinescu C; Raggi MA; Mercolini L; Ozdemir V
J Clin Psychopharmacol; 2012 Feb; 32(1):110-3. PubMed ID: 22198458
[TBL] [Abstract][Full Text] [Related]
38. Development and characterisation of a new model of rat trophoblasts.
Beghin D; Delongeas JL; Claude N; Forestier F; Farinotti R; Gil S
Toxicol In Vitro; 2009 Feb; 23(1):141-7. PubMed ID: 19013229
[TBL] [Abstract][Full Text] [Related]
39. Aromatic 2-(thio)ureidocarboxylic acids as a new family of modulators of multidrug resistance-associated protein 1: synthesis, biological evaluation, and structure-activity relationships.
Häcker HG; Leyers S; Wiendlocha J; Gütschow M; Wiese M
J Med Chem; 2009 Aug; 52(15):4586-95. PubMed ID: 19580319
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of limonin on six human cytochrome P450 enzymes and P-glycoprotein in vitro.
Han YL; Yu HL; Li D; Meng XL; Zhou ZY; Yu Q; Zhang XY; Wang FJ; Guo C
Toxicol In Vitro; 2011 Dec; 25(8):1828-33. PubMed ID: 22001672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
